Taner DEMİRER - Overview
Medical School: Ankara University ,Medical School Ankara-Turkey. Degree: M.D. Date: 08/01/84
Research Associate, Chicago Medical School, North Chicago, Illinois (1988-1989)
Flow Cytometry and applications:
a) Prostate Cancer: (Chicago Medical School, Dept. of
Hematology and Oncology, Chicago, Illinois), USA (1989).
b) Mediterranean Lymphomas –IPSID: Medical College of
Wisconsin, Dept. of Hematology/Oncology, Milwaukee, Wisconsin, USA (1990-1992).
Internship: Chicago Medical School (IL-USA) 1989-1990
Residency: Internal Medicine, Medical College of Wisconsin (WI-USA) 1990-1992
Medical Oncology, The Fred Hutchinson Cancer Research Center, University of
Washington, School of Medicine, (Seattle USA) 1992 –1994.
Hematology and Bone Marrow Transplantation, The Fred Hutchinson Cancer
Research Center, University of Washington, School of Medicine, (Seattle USA) 1994-1996
Examinatiıons passed in the USA
Educational Commission for Foreign Medical Graduates (ECFMG) 23, 24 Temmuz 1986
Federal Licensing Examination (FLEX) 21, 22, 23 Haziran 1990
American College of Physicians Self - Assesment Examination (Aralık 1992)
American Board of Internal Medicine (ABIM) 15,16 Eylül 1993
American Board of Medical Oncology 21 Kasım 1997.
Present and Past Academic Rank And Position
Research Associate, Dept. of Hematol / Oncology, Chicago Medical School (USA) 1988-1989
Fellow of American College of Physicians (FACP) (July 1996)
Clinical Investigator, The Fred Hutchinson Cancer Research Center, Seattle (USA), 1996-1997
Professor of Medicine, Ankara University Medical School, Dept. of Hematology and Bone Marrow Transplant Unit (CIC 617). (1997- )
Chairperson of the EBMT Solid Tumor Working Party (March 2001-2007).
Member for FECS (Federation of European Cancer Societies) (March 2001-2007).
President of the Turkish Cancer Advisory Board (June, 2003-2005).
Member of Blood and Blood Products Committee of Turkish Ministry of Health (1999-2004).
Member of the Imported Blood Products Committee of Turkish Ministry of Health 1999-2002).
Member of the Apheresis Committee of Turkish Ministry of Health (2000-2003)
Chief of Drug Registration and Licensing Committee of Turkish Ministry of Health (2001- 2004)
National Director of the EU 6th Framework Program (2002-2003)
Principal Member of The Turkish Academy of Sciences (2012- )
Member, Stem Cells Working Group of The Turkish Academy of Sciences (2012- )
Principal Member of The European Academy of Sciences and Art (EASA) (2013- )
Director, Cancer Working Group of The Turkish Academy of Sciences (2013- )
Member, Member Selection Committee of Global Network of Science Academies-IAP (2013- )
Council Member of the Turkish Academy of Sciences (2015- )
American Board Certified in Internal Medicine (1993)
American Board Certified in Medical Oncology (1997)
American Board Eligible in Hematology
ECFMG Certificate: July 24, 1989
Federal License Examination (FLEX) (Part I-II) : June 20-22, 1990
Diplomate, American Board of Internal Medicine (ABIM): Sept. 21-22, 1993
Diplomate, American Board of Medical Oncology: November , 1997.
Board eligible in Hematology
Washington State (USA) (Since 1992)
Wisconsin (USA) (Since 1989)
Third Highest degree in class of 550. Univ. of Ankara, School of Medicine (08/01/84)
Fellow of American College of Physicians (FACP), July 1996.
Outstanding Clinical Research Award, The Fred Hutchinson Cancer Research
Center, Seattle, WA, (April,1996)
ROCHE Hematology Award of Turkey October 1998
Junior Chamber of International (JCI) Award September 27, 2000
Science Award of The Scientific and Technical Research Council of Turkey, July 2002.
Science Award of The Bayındır Hospital Medical Center, 2004
Grand Honour Award of Turkish Parliament, 2014
As of January, 2018, number of citations for publications cited in the Science
Citaton Index is 3965 and H value of 34 (ISI Web of Knowledge) and 37 (Scopus).
Scientific Committee of the Second International High-Dose Chemotherapy
Congress which was be held on April 9-12th 2002 in Banff, Canada.
President and Scientific Chairman of the EBMT annual meeting in March 2003 in Istanbul, Turkey.
President of the (First, second, third and fourth) (2004-2007) National Medical Oncology Congress of Turkey
President of the (First to sixth) Lymphoma-Myeloma Congress of Turkey (2009- 2014)
Co-President of EBMT Annual Meeting in March 2015 in Istanbul, Turkey
Member of Editorial Reviev Board of Major Journals
1) Bone Marrow Transplantatıon (1998-2014).
2) Stem Cells and Development (1999-2012)
3) World Journal of Hematology (2015- )
Professional Memberships and Societies
American College of Physicians (ACP)
American Society of Clinical Oncology (ASCO)
The American Society of Hematology (ASH)
The American Society for Blood and Marrow Transplantation (ASBMT)
Wisconsin Medical Society (Wisconsin-USA)
Milwaukee County Medical Society (Wisconsin USA)
Washington State Medical Society (Seattle-USA)
European Bone Marrow Transplantation (EBMT)
European Hematology Association (EHA)
European Society of Medical Oncology (ESMO)
Turkish Society of Hematology
Turkish Society of Clinical Oncology
1) High dose chemotherapy with recombinant human growth factors for cytoreduction and peripheral blood stem cell mobilization.
2) High dose chemotherapy followed by autologous stem cell rescue for treatment of ovarian, breast, testicular and small cell lung cancer.
3) Autologous stem cell transplantation using peripheral blood stem cells in patient with multiple myeloma, lymphoma and acute myelogenous leukemias.
4) Allogeneic stem cell transplantation with reduced intensity regimens in patients with refractory solid tumors.
5) Allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies.